Omar Castaneda-Puglianini

33PUBLICATIONS
167CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Oct 23, 2026
Impact of extramedullary plasmacytoma on outcomes in patients with relapsed refractory multiple myeloma treated with talquetamab: U.S. Myeloma Immunotherapy Consortium.

|Jul 21, 2026
Chronic graft-versus-host disease after PTCy-based prophylaxis vs non-PTCy prophylaxis.

|Jul 08, 2026
Rapid peak cilta-cel expansion is associated with delayed neurotoxicity in multiple myeloma.

|Jul 02, 2026
Real-world outcomes with BCMA- and GPRC5D-targeting bispecific antibodies in plasma cell leukemia.

|Jun 20, 2026
Expanded antigen-specific donor regulatory T cells for GVHD prevention.

|Jun 11, 2026
Product-intrinsic NF-κB-driven transcriptional programs connote durability of CAR-T response in multiple myeloma.

Pageof 6

Frequent Collaborators

20 joint publications

Doris K Hansen

15 joint publications

Surbhi Sidana

13 joint publications

Larry D Anderson

13 joint publications

Krina Patel